Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Cancers|June 13, 2025
Efficacy and Safety of TROP-2-Targeting Antibody-Drug Conjugate Treatment in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer: A Systematic Review and Pooled Analysis of Reconstructed Patient DataSara Stumpo, Andrea Carlini, Francesco Mantuano, et al.Journal of Clinical Medicine|December 23, 2023
Extrapulmonary Neuroendocrine Carcinomas: Current Management and Future PerspectivesSara Stumpo, Maria Giovanna Formelli, Irene Persano, et al.JTO Clinical and Research Reports|April 20, 2026
Efficacy of Adding Immune Checkpoint Inhibition to Chemotherapy, With or Without VEGF Inhibition, in Patients With Advanced <i>EGFR</i>-Mutated NSCLC: A Systematic Review and Meta-Analysis With Reconstructed Individual Patient DataAlessandro Di Federico, Sara Stumpo, Linda Danielli, et al.The Lancet. Oncology|October 2, 2025
Long-term overall survival with dual CTLA-4 and PD-L1 or PD-1 blockade and biomarker-based subgroup analyses in patients with advanced non-small-cell lung cancer: a systematic review and reconstructed individual patient data meta-analysisAlessandro Di Federico, Sara Stumpo, Francesco Mantuano, et al.JAMA Oncology|June 4, 2026
PD-(L)1 Inhibitor Monotherapy vs Chemoimmunotherapy for Advanced NSCLC With High PD-L1 Expression: A Systematic Review and Meta-AnalysisAlessandro Di Federico, Samuele Compagno, Francesco Mantuano, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2026
Clinical significance of EGFR amplification in patients with EGFR-mutated metastatic non-small cell lung cancer receiving first-line osimertinibAlessandro Di Federico, Federica Pecci, Mark Jeng, et al.Pageof 1